Where does Arch Oncology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arch Oncology, Inc. ranks #30,866 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arch Oncology, Inc. hold?

Arch Oncology, Inc. holds 8 US utility patents granted between 2019 and 2023, spanning 4 technology areas.

What is Arch Oncology, Inc.'s Innovation Score?

Arch Oncology, Inc. has an Innovation Score of 23.0 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arch Oncology, Inc. focus on?

Arch Oncology, Inc.'s top technology area is C07K (Peptides) with 8 patents, ranking #1,078 of 3,615 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Arch Oncology, Inc.'s patent grant rate increasing or decreasing?

Arch Oncology, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Arch Oncology, Inc.'s patents?

Arch Oncology, Inc.'s patents average 10.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arch Oncology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arch Oncology, Inc.

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arch ranks #30,866 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#30,866
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (23.0/100): 10.1
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30866 · US Corporation #30,866 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #30,866/49,997
PHOTO-FINISH Aptina Imaging
CPC-NARROW C07K · 4 areas
INNOV-THIN 23.0/100
CLAIMS-PAR 10.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aptina Imaging Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arch’s 23.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (33%) Velocity 2.2 pts (10%) Breadth 7.1 pts (31%) Claim depth 6.1 pts (27%)

Qualcomm Incorporated · highest

85
Arch Oncology · this assignee

23
3D Lighting… · lowest

7

What this shows Arch's Innovation Score is 23.0/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arch?

Each dot is one of Arch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arch’s own 10.1 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Arch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arch's grants concentrate

Arch Oncology, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Arch sits between Aptina Imaging Corporation and Arebus LLC.

Arch's three-year grant acceleration

Arch Oncology, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aptina Imaging

8
Aqseptence Group…

8
Aquatron Robotic…

8
Aramara Beauty

8
Arctic Sand

8
Arcus Hunting

8
Area-i

8
Arebus

8
Arch Oncology ◀

8

What this shows Arch holds 8 patents at rank #30,915, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arch

By rank, the assignees closest to #30,915 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Arch's primary technology class.

Arch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Arch Oncology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	25.0%
2020	3	37.5%
2021	1	12.5%
2022	1	12.5%
2023	1	12.5%

Which technologies does Arch Oncology, Inc. patent most?

C07K - Peptides 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arch Oncology, Inc.'s patent record in context - here's where to go next.

Arch Oncology, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #30,866 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arch Oncology, Inc. against Aptina Imaging Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.